Search results
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 5 hours ago"Overall, we believe the (briefing documents) appear bullish on approval with only a low probability...
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
Forbes· 14 hours agoA panel of experts advising the Food and Drug Administration could on Monday recommend Eli Lilly’s...
Vista Outdoor weighs new $2 billion bid for its ammunition business
Star Tribune (Minneapolis) via Yahoo Finance· 29 minutes agoA last-minute bidder has emerged with an offer to acquire the Kinetic Group, the ammunition business...
Tesla shareholders will vote on Elon Musk's controversial $56B pay package this week: Here's what's...
Yahoo Finance· 4 hours agoFor Tesla, boardroom drama will be on full display on Thursday, when the EV maker will announce the...
A Combined Flu and COVID-19 Shot May Be Coming
Time via Yahoo News· 1 hour agoThat data will also help the U.S. Food and Drug Administration (FDA) when it reviews the company’s request for approval of the combination shot, which...
Planning commission recommends approval of rezoning requests
The Daily Citizen, Dalton, Ga. via Yahoo News· 7 days agoJun. 3—The Dalton-Varnell-Whitfield County Planning Commission recently recommended the approval of several rezonings. The planning commission makes recommendations ...
Approval recommended for up to 90 homes in Great Witley
BBC News· 7 days agoPlanning officers have recommended the approval of plans to build up to 90 new homes in a...
Thorney Primary School plans recommended for approval
BBC News· 6 days agoA new school would help an ageing primary cope with more pupils, according to a planning...
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
Motley Fool via Yahoo Finance· 7 hours agoThe Motley Fool has positions in and recommends Compass Pathways Plc. The Motley Fool has a...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 9 hours agoIn my view, Moderna has a good chance of winning approvals over the next few years for many, if not all, of its late-stage programs. Moderna isn't a...
